<VariationArchive VariationID="1710219" VariationName="NM_014491.4(FOXP2):c.1540del (p.Arg514fs)" VariationType="Deletion" Accession="VCV001710219" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2022-10-15" MostRecentSubmission="2022-10-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1708613" VariationID="1710219">
      <GeneList>
        <Gene Symbol="FOXP2" FullName="forkhead box P2" GeneID="93986" HGNC_ID="HGNC:13875" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>7q31.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="114086327" stop="114693765" display_start="114086327" display_stop="114693765" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="113726364" stop="114333826" display_start="113726364" display_stop="114333826" Strand="+" />
          </Location>
          <OMIM>605317</OMIM>
          <Haploinsufficiency last_evaluated="2012-09-19" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FOXP2">Little evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-09-19" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FOXP2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_014491.4(FOXP2):c.1540del (p.Arg514fs)</Name>
      <CanonicalSPDI>NC_000007.14:114659425:AA:A</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>7q31.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="114659426" stop="114659426" display_start="114659426" display_stop="114659426" variantLength="1" positionVCF="114659425" referenceAlleleVCF="TA" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="114299481" stop="114299481" display_start="114299481" display_stop="114299481" variantLength="1" positionVCF="114299480" referenceAlleleVCF="TA" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>R513fs</ProteinChange>
      <ProteinChange>R514fs</ProteinChange>
      <ProteinChange>R531fs</ProteinChange>
      <ProteinChange>R539fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.114299482del" Assembly="GRCh37">
            <Expression>NC_000007.13:g.114299482del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.114659427del" Assembly="GRCh38">
            <Expression>NC_000007.14:g.114659427del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007491.3" sequenceAccession="NG_007491" sequenceVersion="3" change="g.578118del">
            <Expression>NG_007491.3:g.578118del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001172766.3" sequenceAccession="NM_001172766" sequenceVersion="3" change="c.1537del">
            <Expression>NM_001172766.3:c.1537del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001166237.1" sequenceAccession="NP_001166237" sequenceVersion="1" change="p.Arg513fs">
            <Expression>NP_001166237.1:p.Arg513fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_014491.4" sequenceAccession="NM_014491" sequenceVersion="4" change="c.1540del" MANESelect="true">
            <Expression>NM_014491.4:c.1540del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_055306.1" sequenceAccession="NP_055306" sequenceVersion="1" change="p.Arg514fs">
            <Expression>NP_055306.1:p.Arg514fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_148898.4" sequenceAccession="NM_148898" sequenceVersion="4" change="c.1615del">
            <Expression>NM_148898.4:c.1615del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_683696.2" sequenceAccession="NP_683696" sequenceVersion="2" change="p.Arg539fs">
            <Expression>NP_683696.2:p.Arg539fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_148899.2" sequenceAccession="NM_148899" sequenceVersion="2" change="c.1264delA">
            <Expression>NM_148899.2:c.1264delA</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_683697.1" sequenceAccession="NP_683697" sequenceVersion="1" change="p.Arg422Glyfs">
            <Expression>NP_683697.1:p.Arg422Glyfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_148900.4" sequenceAccession="NM_148900" sequenceVersion="4" change="c.1591del">
            <Expression>NM_148900.4:c.1591del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_683698.2" sequenceAccession="NP_683698" sequenceVersion="2" change="p.Arg531fs">
            <Expression>NP_683698.2:p.Arg531fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_033766.2" sequenceAccession="NR_033766" sequenceVersion="2" change="n.1908del">
            <Expression>NR_033766.2:n.1908del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_033767.2" sequenceAccession="NR_033767" sequenceVersion="2" change="n.2154del">
            <Expression>NR_033767.2:n.2154del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_014491.4(FOXP2):c.1540del (p.Arg514fs) AND Childhood apraxia of speech" Accession="RCV002291146" Version="9">
        <ClassifiedConditionList TraitSetID="1402">
          <ClassifiedCondition DB="MedGen" ID="C0750927">Childhood apraxia of speech</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2022-03-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-03-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-10-15" MostRecentSubmission="2022-10-15">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="1402" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3810" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Speech-language disorder 1</ElementValue>
                <XRef ID="Speech-language+disorder+1/9325" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Childhood apraxia of speech</ElementValue>
                <XRef ID="MONDO:0011184" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">DEVELOPMENTAL VERBAL DYSPRAXIA</ElementValue>
                <XRef Type="MIM" ID="602081" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605317.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605317.0002" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SPEECH AND LANGUAGE DISORDER WITH OROFACIAL DYSPRAXIA</ElementValue>
                <XRef Type="MIM" ID="602081" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DVD</ElementValue>
                <XRef Type="MIM" ID="602081" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">SPCH1</ElementValue>
                <XRef Type="MIM" ID="602081" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CAS</ElementValue>
                <XRef Type="MIM" ID="602081" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">FOXP2-Related Speech and Language Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12889" />
                <XRef ID="12889" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">All FOXP2-related speech and language disorders, regardless of the underlying genetic alteration, have a core phenotype: childhood apraxia of speech (CAS), a disorder of speech motor programming or planning that affects the production, sequencing, timing, and stress of sounds, syllables, and words. All individuals with CAS – whether caused by an alteration of FOXP2 or of an unknown cause – have difficulties in automatically and accurately sequencing speech sounds into syllables, syllables into words, and words into sentences with the correct prosody. Additional findings in FOXP2-related speech and language disorders can include oral motor dyspraxia (difficulty planning or programming oral movements on command); dysarthria (a neuromuscular-based speech disorder that may affect nasal resonance, voice quality, prosody, and breath support for speech); moderate to severe receptive and expressive language disorder; and reading and spelling impairments. The underlying genetic cause of FOXP2-related speech and language disorders is either disruption of FOXP2 only (referred to in this GeneReview as FOXP2-only-related speech and language disorder) or large copy number variants (i.e., contiguous gene deletions), structural variants (i.e., chromosome translocation or inversion), or maternal uniparental disomy of chromosome 7 (UPD7) involving FOXP2 (here referred to as FOXP2-plus-related speech and language disorders). The genetic alteration determines if only speech and language problems are present (FOXP2-only-related speech and language disorder) or if more global developmental and behavioral issues are likely to be present as well (FOXP2-plus-related speech and language disorder). In FOXP2-only-related disorders, nonverbal (performance) IQ is typically more preserved compared to verbal IQ. Fine motor skills may be impaired (e.g., buttoning clothes, tying shoelaces), yet gross motor skills are normal. Autistic features and dysmorphic findings have been reported in a few affected individuals. In FOXP2-plus-related disorders oral motor deficits, global developmental delay, and autism spectrum disorder are common.</Attribute>
                <XRef ID="NBK368474" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">27336128</ID>
                <ID Source="BookShelf">NBK368474</ID>
              </Citation>
              <XRef ID="209908" DB="Orphanet" />
              <XRef ID="C0750927" DB="MedGen" />
              <XRef ID="MONDO:0011184" DB="MONDO" />
              <XRef Type="MIM" ID="602081" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5048650" SubmissionDate="2022-10-06" DateLastUpdated="2022-10-15" DateCreated="2022-10-15">
        <ClinVarSubmissionID localKey="22Ord8479|OMIM:602081" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002583410" DateUpdated="2022-10-15" DateCreated="2022-10-15" Type="SCV" Version="1" SubmitterName="Clinical Genetics Laboratory, University Hospital Schleswig-Holstein" OrgID="508136" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FOXP2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014491.4:c.1540del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="602081" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12129354</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5048650" TraitType="Disease" MappingType="XRef" MappingValue="602081" MappingRef="OMIM">
        <MedGen CUI="C0750927" Name="Childhood apraxia of speech" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

